Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Amortization of Deferred Charges (2017 - 2022)

Insight Molecular Diagnostics' Amortization of Deferred Charges history spans 3 years, with the latest figure at $1000.0 for Q3 2022.

  • On a quarterly basis, Amortization of Deferred Charges fell 92.31% to $1000.0 in Q3 2022 year-over-year; TTM through Dec 2022 was $12000.0, a 78.57% decrease, with the full-year FY2022 number at $12000.0, down 78.57% from a year prior.
  • Amortization of Deferred Charges hit $1000.0 in Q3 2022 for Insight Molecular Diagnostics, down from $4000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for IMDX hit a ceiling of $35000.0 in Q1 2020 and a floor of $1000.0 in Q3 2022.
  • Historically, Amortization of Deferred Charges has averaged $15454.5 across 3 years, with a median of $14000.0 in 2021.
  • Biggest five-year swings in Amortization of Deferred Charges: tumbled 36.36% in 2021 and later crashed 92.31% in 2022.
  • Tracing IMDX's Amortization of Deferred Charges over 3 years: stood at $22000.0 in 2020, then plummeted by 54.55% to $10000.0 in 2021, then plummeted by 90.0% to $1000.0 in 2022.
  • Business Quant data shows Amortization of Deferred Charges for IMDX at $1000.0 in Q3 2022, $4000.0 in Q2 2022, and $7000.0 in Q1 2022.